Our Office
オフィスアワー
Front OncolJan2022 Insulin-like growth factor 2 mRNA binding protein 3
promotes cell proliferation of malignant mesothelioma cells by downregulating p27Kip1.
Endo Ihiro, Amatya VJ, Kushitani K, Kambara T, Nakagiri T, Fujii Y, Takeshima Y.
Front. Oncol. doi: 10.3389/fonc.2021.795467, 2022 read more
Endo Ihiro, Amatya VJ, Kushitani K, Kambara T, Nakagiri T, Fujii Y, Takeshima Y.
Front. Oncol. doi: 10.3389/fonc.2021.795467, 2022 read more
Oncol RepDec2021
Downregulation of lncRNA PVT1 inhibits
proliferation and migration of mesothelioma cells by targeting FOXM1.
Fujii Y, Amatya VJ, Kushitani K, Suzuki R., Kai Y, Kambara T, Takeshima Y.
Oncol Rep. 2022 Feb;47(2):. read more
Fujii Y, Amatya VJ, Kushitani K, Suzuki R., Kai Y, Kambara T, Takeshima Y.
Oncol Rep. 2022 Feb;47(2):. read more
Transl Lung Cancer ResFEb2021
Glypican-1 is a novel immunohistochemical marker to
differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the
lung.
Kai Y, Amatya VJ, Kushitani K, Kambara T, Suzuki R, Fujii Y, Tsutani Y, Miyata Y, Okada M, Takeshima Y.
Transl Lung Cancer Res. 2021 Feb;10(2):766-775. read more
Kai Y, Amatya VJ, Kushitani K, Kambara T, Suzuki R, Fujii Y, Tsutani Y, Miyata Y, Okada M, Takeshima Y.
Transl Lung Cancer Res. 2021 Feb;10(2):766-775. read more
Am J Surg PatholJun2020 SOX6 Is a Novel Immunohistochemical Marker for
Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma
Kambara T, Amatya VJ, Kushitani K, Suzuki R, Fujii Y, Kai Y, Miyata Y, Okada M, Takeshima Y.
Am J Surg Pathol. 2020 Sep;44(9):1259-1265. read more
Kambara T, Amatya VJ, Kushitani K, Suzuki R, Fujii Y, Kai Y, Miyata Y, Okada M, Takeshima Y.
Am J Surg Pathol. 2020 Sep;44(9):1259-1265. read more
Oncol LettersApr2020 Inhibition of miR‑18a‑3p reduces proliferation of
mesothelioma cells and sensitizes them to cisplatin
Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Fujii Y, Takeshima Y.
Oncology Letters, 2020 Jun; 19(6):4161-4168 read more
Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Fujii Y, Takeshima Y.
Oncology Letters, 2020 Jun; 19(6):4161-4168 read more
HistopatholMar2019 Mucin 21 is a novel, negative immunohistochemical
marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.
Kai Y, Amatya VJ, Kushitani K, Kambara T, Suzuki R, Tsutani Y, Miyata Y, Okada M, Takeshima Y.
Histopathology. 2019 Mar;74(4):545-554. read more
Kai Y, Amatya VJ, Kushitani K, Kambara T, Suzuki R, Tsutani Y, Miyata Y, Okada M, Takeshima Y.
Histopathology. 2019 Mar;74(4):545-554. read more
Mod PatholJan2019 Reply to 'MUC4 staining in sarcomatoid carcinomas'
by Berg et al.
Amatya VJ, Kushitani K, Mawas AS, Miyata Y, Okada M, Kishimoto T, Inai K, Takeshima Y.
Mod Pathol 32:158, 2019. read more
Amatya VJ, Kushitani K, Mawas AS, Miyata Y, Okada M, Kishimoto T, Inai K, Takeshima Y.
Mod Pathol 32:158, 2019. read more
Front OncolDec2018 miR-182 and miR-183 Promote Cell Proliferation and
Invasion by Targeting FOXO1 in Mesothelioma.
Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Takeshima Y.
Front Oncol 8:446, 2018 read more
Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Takeshima Y.
Front Oncol 8:446, 2018 read more
Mod PatholJan2018
Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung
adenocarcinoma
Amatya VJ, Kushitani K, Kai Y, Suzuki R, Miyata Y, Okada M, Takeshima Y.
Mod Pathol 31(5):809-815, 2018 read more
Amatya VJ, Kushitani K, Kai Y, Suzuki R, Miyata Y, Okada M, Takeshima Y.
Mod Pathol 31(5):809-815, 2018 read more
Oncol LettJan2018
Utility of Survivin, BAP1, and Ki‑67 immunohistochemistry in distinguishing epithelioid mesothelioma from
reactive mesothelial hyperplasia
Kushitani K, Amatya VJ, Mawas AS, Suzuki R, Miyata Y, Okada M, Inai K, Kishimoto T, Takeshima Y.
Oncol Lett 15(3):3540-3547, 2018 read more
Kushitani K, Amatya VJ, Mawas AS, Suzuki R, Miyata Y, Okada M, Inai K, Kishimoto T, Takeshima Y.
Oncol Lett 15(3):3540-3547, 2018 read more
Sci RepJan2018
MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and
squamous cell carcinoma of the lung.
Mawas AS, Amatya VJ, Kushitani K, Kai Y, Miyata Y, Okada M, Takeshima Y.
Sci Rep 8(1):134. read more
Mawas AS, Amatya VJ, Kushitani K, Kai Y, Miyata Y, Okada M, Takeshima Y.
Sci Rep 8(1):134. read more
Am J Surg PatholAug2017
Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid
Mesothelioma by Transcriptome Microarray Analysis for its Differentiation From Pulmonary
Adenocarcinoma.
Kuraoka M, Amatya VJ, Kushitani K, Mawas AS, Miyata Y, Okada M, Kishimoto T, Inai K, Nishisaka T, Sueda T, Takeshima Y.
Am J Surg Pathol. 2017; 41(8):1045-1052 read more
Kuraoka M, Amatya VJ, Kushitani K, Mawas AS, Miyata Y, Okada M, Kishimoto T, Inai K, Nishisaka T, Sueda T, Takeshima Y.
Am J Surg Pathol. 2017; 41(8):1045-1052 read more
Mod PatholMay2017
MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural
sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
Amatya VJ, Kushitani K, Mawas AS, Miyata Y, Kishimoto T, Okada M, Inai K, Takeshima Y.
Mod Pathol. 2017; 30(5): 672-681 read more
Amatya VJ, Kushitani K, Mawas AS, Miyata Y, Kishimoto T, Okada M, Inai K, Takeshima Y.
Mod Pathol. 2017; 30(5): 672-681 read more
Int J oncolMar2017 PIM1 knockdown inhibits cell proliferation and
invasion of mesothelioma cells.
Mawas AS, Amatya VJ, Suzuki R, Kushitani K, Mohi El-Din MM, Takeshima Y.
Int J Oncol; 2017 Mar; 50(3):1029-1034 read more
Mawas AS, Amatya VJ, Suzuki R, Kushitani K, Mohi El-Din MM, Takeshima Y.
Int J Oncol; 2017 Mar; 50(3):1029-1034 read more
HistopatholFeb2017 Utility and pitfall of Immunohistochemistry in the
Differential Diagnosis between Epithelioid Mesothelioma and Poorly Differentiated Lung Squamous Cell
Carcinoma.
Kushitani K, Amatya VJ, Okada Y, Katayama Y, Mawas AS, Miyata Y, Okada M, Inai K, Kishimoto T, Takeshima Y.
Histopathology. 2017; 70(3): 375-384 read more
Kushitani K, Amatya VJ, Okada Y, Katayama Y, Mawas AS, Miyata Y, Okada M, Inai K, Kishimoto T, Takeshima Y.
Histopathology. 2017; 70(3): 375-384 read more
